1. A medicament for the treatment of pathological syndrome, comprising an activated - potentiated form of antibodies to histamine, characterized in that it is in the form of a pharmaceutical composition and comprises, as additional - reinforcing components activated-potentiated form of antibodies to tumor necrosis factor - alpha (TNF-α ) and activated - potentiated form of antibodies to brain-specific protein S-100.2. A medicament according to claim 1, characterized in that the pathological syndrome are functional disorders kishechnika.3. A medicament according to claim 1 or 2, characterized in that the activated - potentiated form of antibodies to histamine, activated - potentiated form of antibodies to TNF-α and activated - S-100 potentiated form of antibodies to brain-specific proteins are used in the form of activated - potentiated aqueous or hydroalcoholic solution obtained in the process of successive dilutions of multiple respective matrix solution of antibodies in an aqueous or aqueous-alcoholic solvent, and an intermediate external mechanical Skogen effects - vertical vstryahivaniya.4. A medicament according to claim 3, characterized in that the pharmaceutical composition is in a solid dosage form contains an effective amount of granules of the neutral carrier saturated with a mixture of activated - potentiated form of antibodies to histamine activated - potentiated forms of antibodies to TNF-α and activated - potentiated antibodies to brain-specific protein S-100, and pharmaceutically acceptable dobavki.5. with drug1. Лекарственное средство для лечения патологического синдрома, содержащее активированную - потенцированную форму антител к гистамину, характеризующееся тем, что выполнено в виде фармацевтической композиции и содержит в качестве дополнительных - усиливающих компонентов активированную-потенцированную форму антител к фактору некроза опухоли - альфа (ФНО-α) и активированную - потенцированную форму антител к мозгоспецифическому белку S-100.2. Лекарс
